Nayereh Ghoreishi-Haack
Overview
Explore the profile of Nayereh Ghoreishi-Haack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cannon M, Dempsey E, Cosantino A, Chandel N, Ghoreishi-Haack N
Res Sq
. 2024 Apr;
PMID: 38645111
Background: This study aimed to evaluate the effects of continuous administration of xylitol (a commonly used dental prebiotic) via a subcutaneous osmotic minipump in a B16F10 syngeneic mouse model. Methods:...
2.
Ouyang W, Kilner K, Xavier R, Liu Y, Lu Y, Feller S, et al.
Neuron
. 2024 Mar;
112(11):1764-1777.e5.
PMID: 38537641
Comprehensive, continuous quantitative monitoring of intricately orchestrated physiological processes and behavioral states in living organisms can yield essential data for elucidating the function of neural circuits under healthy and diseased...
3.
Hu Z, Guo H, An D, Wu M, Kaura A, Oh H, et al.
Adv Mater
. 2024 Feb;
36(19):e2309421.
PMID: 38339983
Bioresorbable electronic devices as temporary biomedical implants represent an emerging class of technology relevant to a range of patient conditions currently addressed with technologies that require surgical explantation after a...
4.
Ouyang W, Lu W, Zhang Y, Liu Y, Kim J, Shen H, et al.
Nat Biomed Eng
. 2023 Apr;
7(10):1252-1269.
PMID: 37106153
Fully implantable wireless systems for the recording and modulation of neural circuits that do not require physical tethers or batteries allow for studies that demand the use of unconstrained and...
5.
Guo H, Bai W, Ouyang W, Liu Y, Wu C, Xu Y, et al.
Nat Commun
. 2022 May;
13(1):3009.
PMID: 35637230
Continuous, real-time monitoring of perfusion after microsurgical free tissue transfer or solid organ allotransplantation procedures can facilitate early diagnosis of and intervention for anastomotic thrombosis. Current technologies including Doppler systems,...
6.
Patel M, Peltier H, Matulenko M, Koenig J, Scanio M, Gum R, et al.
Bioorg Med Chem
. 2022 Apr;
63:116743.
PMID: 35436748
The voltage-gated sodium channel Na1.7 is an attractive target for the treatment of pain based on the high level of target validation with genetic evidence linking Na1.7 to pain in...
7.
Yang Q, Wei T, Yin R, Wu M, Xu Y, Koo J, et al.
Nat Mater
. 2021 Jul;
20(11):1559-1570.
PMID: 34326506
Flexible electronic/optoelectronic systems that can intimately integrate onto the surfaces of vital organ systems have the potential to offer revolutionary diagnostic and therapeutic capabilities relevant to a wide spectrum of...
8.
Morrison G, Asiedu M, Priebe J, Dunning J, Ghoreishi-Haack N, Kroes R, et al.
Neurobiol Pain
. 2020 Jan;
7:100039.
PMID: 31909296
Previous studies have shown that oral administration of the NMDAR modulator NYX-2925 alleviates pain in several animal models of neuropathic pain and this appears to be through mPFC, but not...
9.
Burgdorf J, Ghoreishi-Haack N, Cearley C, Kroes R, Moskal J
Neuroreport
. 2019 Aug;
30(13):863-866.
PMID: 31373964
In humans, chronic pain is often expressed as a spontaneous emotional response which can lead to fragmented sleep. Rat 50-kHz and 20-kHz ultrasonic vocalizations are well-established measures of positive and...
10.
Ghoreishi-Haack N, Priebe J, Aguado J, Colechio E, Burgdorf J, Bowers M, et al.
J Pharmacol Exp Ther
. 2018 Jul;
366(3):485-497.
PMID: 29986951
NYX-2925 [(2S,3R)-3-hydroxy-2-((R)-5-isobutyryl-1-oxo-2,5-diazaspiro[3.4]octan-2-yl)butanamide] is a novel -methyl-d-aspartate (NMDA) receptor modulator that is currently being investigated in phase 2 clinical studies for the treatment of painful diabetic peripheral neuropathy and fibromyalgia. Previous...